Search
for
Sort by
Research 121–150 of 1000+
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- 0917 Finasteride is Associated with a Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Medical treatments for male and female pattern hair loss
- Androgenetic Alopecia: An Update of Treatment Options
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Alopecia Areata: An Updated Review for 2023
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Expert System for Hair Loss Diagnosis and Treatment
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Low level laser therapy and hair regrowth: an evidence-based review
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Nanotechnology-Based Cosmetics for Hair Care
- A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
- Bidirectional Barbed Sutures for Wound Closure: Evolution and Applications
- Robotic Hair Restoration
- ANDROGENETIC ALOPECIA
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- Laser Resurfacing
- Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Topical minoxidil: review of efficacy and safety.
- Photobiomodulation therapy for androgenetic alopecia: A clinician’s guide to home-use devices cleared by the Federal Drug Administration
- Assessment of biotin supplementation among patients in an outpatient dermatology clinic
- Controversy: Synthetic hairs and their role in hair restoration?
- LASER HAIR TRANSPLANTATION